NCT00374751View on ClinicalTrials.gov

Effect of Samarium on the Relief of Pain Due to Vertebral Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2016

Conditions
CancerMetastasisPain
Interventions
DRUG

Samarium (153SM)

The Samarium is introduced into the vertebral cavity using a 2-way valve by the radiation oncologist. The cement is then introduced via the same 2-way valve into the vertebral cavity by the neurosurgeon.

Trial Locations (1)

11215

New York Methodist Hospital, Brooklyn

All Listed Sponsors
lead

New York Presbyterian Brooklyn Methodist Hospital

OTHER

NCT00374751 - Effect of Samarium on the Relief of Pain Due to Vertebral Metastases | Biotech Hunter | Biotech Hunter